ConductScience.org, home

Paper35274201

Research progress of whole-cell-SELEX selection and the application of cell-targeting aptamer.

Duan Y and 3 others. Mol Biol Rep, 2022. Cited by 39 papers, by iCite.

Cite this record

ConductScience Library. Research progress of whole-cell-SELEX selection and the application of cell-targeting aptamer. Papers, record 35274201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35274201

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Research progress of whole-cell-SELEX selection and the application of cell-targeting aptamer.
PubMed
Journal
Mol Biol Rep
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
4.07
iCite
Revised in PubMed
2026-10-28
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Duan YYu
2Zhang CChunyun
3Wang YYuanyuan
4Chen GGuofu

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aptamers, NucleotideMajor topic
SELEX Aptamer TechniqueMajor topic
Animals
Flow Cytometry
Ligands

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
ZR2020MD081Shandong Provincial Natural Science Foundation, ChinaPubMed
No. 31600309National Scientific Foundation of ChinaPubMed
41476086National Scientific Foundation of ChinaPubMed
No. HIT.NSRIF.201702HIT Scientific Research Innovation FundPubMed

Source PubMed

Download CSV of grants

References79

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132546848High-efficiency enrichment enables identification of aptamers to circulating Plasmodium falciparum-infected erythrocytes.Sci Rep2020https://conductscience.org/library/papers/32546848PubMed
222927983Development of an aptamer-based concentration method for the detection of Trypanosoma cruzi in blood.PLoS One2012https://conductscience.org/library/papers/22927983PubMed
325184732Single-walled carbon nanotubes (SWCNTs)-assisted cell-systematic evolution of ligands by exponential enrichment (cell-SELEX) for improving screening efficiency.Anal Chem2014https://conductscience.org/library/papers/25184732PubMed
421368158Activatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alteration.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21368158PubMed
533257166Light spectra as triggers for sorting improved strains of Tisochrysis lutea.Bioresour Technol2021https://conductscience.org/library/papers/33257166PubMed
623381690Selection of aptamers against inactive Vibrio alginolyticus and application in a qualitative detection assay.Biotechnol Lett2013https://conductscience.org/library/papers/23381690PubMed
710198434Combinatorial selection of high affinity RNA ligands to live African trypanosomes.Nucleic Acids Res1999https://conductscience.org/library/papers/10198434PubMed
89501188High affinity ligands from in vitro selection: complex targets.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9501188PubMed
933132238SELEX-based DNA Aptamer Selection: A Perspective from the Advancement of Separation Techniques.Anal Sci2021https://conductscience.org/library/papers/33132238PubMed
1016582579Antibodies for targeted cancer therapy -- technical aspects and clinical perspectives.Pathobiology2005https://conductscience.org/library/papers/16582579PubMed
1134105524Evolution of DNA aptamers against esophageal squamous cell carcinoma using cell-SELEX.Analyst2021https://conductscience.org/library/papers/34105524PubMed
1230867884An automated microfluidic system for selection of aptamer probes against ovarian cancer tissues.Biomicrofluidics2019https://conductscience.org/library/papers/30867884PubMed
1324043813Structural basis for discriminatory recognition of Plasmodium lactate dehydrogenase by a DNA aptamer.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/24043813PubMed
1434110790Aptamer-Targeted Photodynamic Platforms for Tumor Therapy.ACS Appl Mater Interfaces2021https://conductscience.org/library/papers/34110790PubMed
1530685034Selection of highly specific aptamers to Vibrio parahaemolyticus using cell-SELEX powered by functionalized graphene oxide and rolling circle amplification.Anal Chim Acta2019https://conductscience.org/library/papers/30685034PubMed
1628713479Automated selection of aptamers against cholangiocarcinoma cells on an integrated microfluidic platform.Biomicrofluidics2017https://conductscience.org/library/papers/28713479PubMed
1724379378In vitro selection with artificial expanded genetic information systems.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/24379378PubMed
1818566957Recent advances in three-dimensional multicellular spheroid culture for biomedical research.Biotechnol J2008https://conductscience.org/library/papers/18566957PubMed
1933184760Selection and truncation of aptamers for ultrasensitive detection of sulfamethazine using a fluorescent biosensor based on graphene oxide.Anal Bioanal Chem2021https://conductscience.org/library/papers/33184760PubMed
2032600757A novel fluorometric aptasensor based on carbon nanocomposite for sensitive detection of Escherichia coli O157:H7 in milk.J Dairy Sci2020https://conductscience.org/library/papers/32600757PubMed

See all 79 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
42939667Aptamers as Innovative Tools for Prostate Cancer: Tumor Recognition and Biological Activity.Biomolecules2026https://conductscience.org/library/papers/42939667PubMed
42506713SELEX-Based Aptamer Technologies for Toxin Analysis: Screening, Optimization, and Computational Assisted Design.Toxins (Basel)2026https://conductscience.org/library/papers/42506713PubMed
41995347Magnetic-Assisted Aptamer Selection and Isolation of Migrasomes for Application in Lung Adenocarcinoma Proteomic Analysis.J Extracell Vesicles2026https://conductscience.org/library/papers/41995347PubMed
41149295Recent Advances in the Optimization of Nucleic Acid Aptamers and Aptasensors.Biosensors (Basel)2025https://conductscience.org/library/papers/41149295PubMed
41149291Designing the Future of Biosensing: Advances in Aptamer Discovery, Computational Modeling, and Diagnostic Applications.Biosensors (Basel)2025https://conductscience.org/library/papers/41149291PubMed
40772226Recent advances in aptamer-based biosensing technology for isolation and detection of extracellular vesicles.Front Cell Dev Biol2025https://conductscience.org/library/papers/40772226PubMed
40531391Research Progress on Signal Conversion Based on Aptamer Combined CRISPR/Cas System in Biosensors.Mol Diagn Ther2025https://conductscience.org/library/papers/40531391PubMed
40492939A Combined Aptamer Pulldown-DNAzyme Cleavage Assay for Intact Methicillin Resistant Staphylococcus aureus Cells.Angew Chem Int Ed Engl2025https://conductscience.org/library/papers/40492939PubMed
40451960Screening and characterization of nucleic acid aptamers targeting Brucella surface antigens: identification and analysis of their corresponding binding sites.World J Microbiol Biotechnol2025https://conductscience.org/library/papers/40451960PubMed
40422200Aptamer-ODN Chimeras: Enabling Cell-Specific ODN Targeting Therapy.Cells2025https://conductscience.org/library/papers/40422200PubMed
40376266The prospective approach for aptamers applied in the treatment and molecular diagnostics of ischemic stroke.Front Pharmacol2025https://conductscience.org/library/papers/40376266PubMed
40247402Small extracellular vesicles: the origins, current status, future prospects, and applications.Stem Cell Res Ther2025https://conductscience.org/library/papers/40247402PubMed
40223817Aptamers as innovative tools for malaria diagnosis and treatment: advances and future perspectives.Biol Methods Protoc2025https://conductscience.org/library/papers/40223817PubMed
40190823A novel hybrid approach to overcome defects of CE-SELEX and cell-SELEX in developing aptamers against aspartate β-hydroxylase.Res Pharm Sci2025https://conductscience.org/library/papers/40190823PubMed
40143057The 20th Anniversary of Pegaptanib (MacugenTM), the First Approved Aptamer Medicine: History, Recent Advances and Future Prospects of Aptamers in Therapy.Pharmaceutics2025https://conductscience.org/library/papers/40143057PubMed
39859192Overview and Prospects of DNA Sequence Visualization.Int J Mol Sci2025https://conductscience.org/library/papers/39859192PubMed
39350296Advances in nucleic acid aptamer-based detection of respiratory virus and bacteria: a mini review.Virol J2024https://conductscience.org/library/papers/39350296PubMed
39056626Aptamer Screening: Current Methods and Future Trend towards Non-SELEX Approach.Biosensors (Basel)2024https://conductscience.org/library/papers/39056626PubMed
38785707APPROACH: Sensitive Detection of Exosomal Biomarkers by Aptamer-Mediated Proximity Ligation Assay and Time-Resolved Förster Resonance Energy Transfer.Biosensors (Basel)2024https://conductscience.org/library/papers/38785707PubMed
38652174Aptamer decorated PDA@magnetic silica microparticles for bacteria purification.Mikrochim Acta2024https://conductscience.org/library/papers/38652174PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35274201

GET https://conductscience.org/api/papers/v1/35274201/references?page=2